SRTS
Sensus Healthcare, Inc.
$3.09
+0.04 (+1.31%)
At close · Jul 7
Market Cap
$48.66M
Shares
16,462,059
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.09
Open$3.02
Day$2.94–3.09
52W$2.66–5.92
Avg vol 30d50K
Short int193K · 1.2% float · 2.8d
Short vol2%
Last earningsMay 7, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 13
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 16.1 · calm
Equity put/call 0.69
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−19%
below
Price vs 50-day avg
−4%
below
RSI (14)
55
neutral
MACD trend
Positive
52-week position
13%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+14%
trailing
6-month return
−33%
trailing
YTD return
−22%
this year
Relative strength
−41%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $3 › 200d $4 — 200d above 50d
Institutional flow
Flat
1 of 44 funds reported for Jun 30 · net 0 sh shares
Insider flow
Accumulating
Net +$5.0K over 90 days · 0% sells
Short interest
Falling
1.17% of float · ▼ -3.5% MoM · 2.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
44 holders — mid 3-yr range
Squeeze score
36
low risk · 0–100
Fundamentals
Revenue growth
−34%
Y/Y
Gross margin
43%
contracting
EPS growth
−215%
Y/Y
Free cash flow
$332.0K
Balance sheet
$22.1M
net cash
Quant / Vol
risk profile
Volatility
77%
annualized · 1-yr
Max drawdown
−52%
past year
ATR
4.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
Next earnings call
Aug 3, 2026
Est · unconfirmed
· in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 13, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−19%
Bearish
Price vs 50-day avg
−4%
Neutral
RSI (14)
55
Neutral
MACD trend
Positive
Bullish
52-week position
13%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $3 › 200d $4 — 200d above 50d
Institutional flow
Flat
1 of 44 funds reported for Jun 30 · net 0 sh shares
Insider flow
Accumulating
Net +$5.0K over 90 days · 0% sells
Short interest
Falling
1.17% of float · ▼ -3.5% MoM · 2.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
44 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $3
Now $3 · 13%
52-wk high $6
vs 200-day avg -19%
vs 50-day avg -4%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | -$4.2M | Q1 2026 | — |
| Fair Deal Agreement program active sites | 18 | as of March 31, 2026 | — |
| Fair Deal Agreement program sites pending activation | 9 | as of March 31, 2026 | — |
| Fair Deal Agreement program treatment volume growth | 8% | Q1 2026 vs Q1 2025 | — |
| active FDA sites | 18 | Q1 2026 call | — |
| SRT systems shipped | 14 | Q1 2026 call | — |
| systems shipped purchased vs FDA | 70% | Q1 2026 call | — |
| treatment volumes increase | 8% | Q1 2026 call | — |
| FDA patients treated | 922 | full year | — |
| FDA treatments delivered | 11,411 | full year | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SRTS
this stock
Sensus Healthcare, Inc.
|
$48.66M | -22.4% | +71.3% | — | 1.2% |
|
ABT
Abbott Laboratories
|
$166.45B | -23.1% | +5.7% | 26.8 | 1.3% |
|
SYK
Stryker Corp
|
$126.41B | -5.9% | +11.2% | 38.2 | 1.6% |
|
MDT
Medtronic plc
|
$107.31B | -12.0% | +8.4% | 22.5 | 1.4% |
|
BSX
Boston Scientific Corp
|
$67.33B | -52.5% | +5.5% | 19.0 | 2.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SRTS | +3.3% | +14.4% | -33.0% | +2.3% | -22.4% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | +2.4% | +13.1% | -40.5% | +2.2% | -32.0% |